pharma · NIKA
Anika Therapeutics S.r.l
Anika Therapeutics S.r.l.
Anika Therapeutics S.r.l patent portfolio — 69 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- HENDERSON, NV, EU
- Programs
- 0
- Drugs
- 0
- Patents
- 69
Anika Therapeutics S.r.l patents
69 pharmaceutical patents indexed for Anika Therapeutics S.r.l. 5 expire within 24 months.
Anika Therapeutics S.r.l has 69 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 5 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 6642201
Use of a dipeptide for stimulating repair processes
expired -
US 6620927
Thiol-modified hyaluronan
expired -
US 6613739
Deuterated cyclosporine analogs and their use as immunomodulating agents
expired -
US 6605593
Deuterated cyclosporine analogs and their use as immunomodulating agents
expired -
US 6602715
13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic control
expired -
US 6599750
13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic control
expired -
US 6548081
Bioabsorbable composites of derivatized hyaluronic acid and other biodegradable, biocompatible polymers
expired -
US 6537979
Water-insoluble derivatives of hyaluronic acid crosslinked with a biscarbodiimide
expired -
US 6511988
Activated iododerivatives for the treatment of cancer and aids
expired -
US 6503921
Deuterated rapamycin compounds, methods and uses thereof
expired -
US 6468802
13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic control
expired -
US 6461870
13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic control
expired -
US 6342507
Deuterated rapamycin compounds, method and uses thereof
expired -
US 6210708
Cationic virosomes as transfer system for genetic material
expired -
US 6183742
Applications of lysozyme dimer
expired -
US 6132715
Method of inhibiting biosynthesis of tumor necrosis factor
expired -
US 6123937
Applications of lysozyme dimer
expired -
US 6099835
Method of using antiviral composition
expired -
US 6096727
Method for treating wounds using modified hyaluronic acid crosslinked with biscarbodiimide
expired -
US 6040167
Synthetic membrane vesicles containing functionally active fusion peptides as drug delivery systems
expired -
US 6013679
Water-insoluble derivatives of hyaluronic acid and their methods of preparation and use
expired
Frequently asked questions
How many patents does Anika Therapeutics S.r.l have?
69 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Anika Therapeutics S.r.l patents expire?
5 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.